Autoimmune Disorders: Molecular Mechanisms and Therapeutic Strategies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 700
Special Issue Editor
Interests: rheumatoid arthritis; pathophysiology; biological therapies; systemic connective tissue diseases; scleroderma; interstitial lung disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Autoimmune disorders encompass a broad spectrum of diseases driven by dysregulated immune responses that lead to chronic inflammation, autoantibody production, and progressive tissue damage. Understanding the molecular mechanisms underlying these conditions is crucial for developing targeted therapies that can modulate the immune response while minimizing adverse effects.
This Special Issue, “Autoimmune Disorders: Molecular Mechanisms and Therapeutic Strategies”, aims to provide a comprehensive insight into the pathophysiology of autoimmune diseases.
This Special Issue explores the molecular mechanisms driving autoimmunity, including genetic predisposition, epigenetic modifications, and dysregulated immune signaling. Aberrant activation of T and B cells, defective regulatory T cells, and abnormal cytokine profiles contribute to chronic inflammation and tissue damage.
Advancements in molecular research have identified key signaling pathways involved in autoimmune pathogenesis, such as NF-κB, JAK-STAT, and PI3K-AKT-mTOR. Understanding these pathways has facilitated the development of targeted therapies, including monoclonal antibodies, small-molecule inhibitors, and immune checkpoint modulators. Biologics such as TNF-α inhibitors, IL-6 antagonists, and CD20-targeting therapies have revolutionized treatment approaches, improving disease outcomes in conditions like rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
Emerging therapeutic strategies focus on restoring immune tolerance through regulatory T cell expansion, tolerogenic dendritic cells, and antigen-specific immunotherapy. Advances in precision medicine and biomarker discovery are enhancing personalized treatment, optimizing drug responses, and minimizing adverse effects. This Special Issue highlights current molecular insights and therapeutic innovations in autoimmune diseases, emphasizing translational research that bridges basic immunology with clinical applications.
Dr. Katarzyna Romanowska-Próchnicka
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular mechanisms
- immune signaling pathways
- targeted therapies
- biomarkers
- autoimmune pathogenesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
